Skip to content

A Registry Study on Genetics and Biomarkers of Thoracic Aortic Aneurysm/Dissection

A Chinese Registry to Determine the Genetic Risk Factors and Serumal Biomarkers for Thoracic Aortic Aneurysm/Dissection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03010514
Acronym
ARSGBTAAD
Enrollment
600
Registered
2017-01-05
Start date
2016-10-31
Completion date
2019-10-31
Last updated
2017-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysm, Dissecting, Aortic Aneurysm, Thoracic

Brief summary

This is a national registry study to determine genetic risk factor and serial biomarkers of thoracic aortic aneurysm/dissection

Interventions

None listed

Sponsors

Beijing Institute of Heart, Lung and Blood Vessel Diseases
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Case Inclusion Criteria: 1. Subject who was diagnosed as thoracic aortic aneurysm/dissection by CT angiography, interventional angiography or vascular ultrasound; 2. Age is less than 80 years old; 3. male and non pregnancy female; 4. Subject understands study requirements aand agrees to sign an informed consent form prior to any study procedures. Case

Exclusion criteria

Subject has one of the following: 1. Pseudoaneurysm; 2. Previous infection or trauma in the damaged part of aorta; 3. Pregnancy female; 4. Participate in other clinical trials in the last 1 months. Control Inclusion Criteria: 1. Age and gender are matched with cases; 2. No aortic disease was detected by outpatient ultrasound; 3. No family history of cardiovascular disease; 4. Normal biochemical indicators; Criteria for culling, shedding and suspension testing: 1. Culling: Unqualified cases and controls. Data of culled subjects can not be used for statistical analysis; 2. Shedding: Subject that self withdrawal, loss to follow-up, or quitted by doctors; Reasons for shedding should be indicated for each shed subject. 3. Suspension: a) The researchers found significant safety problems or wrong study design; b) Researchers cannot continue clinical research due to funding or management reasons; c) Director ends the study. When suspension happens, all the CRF table should be reserved for future reference.

Design outcomes

Primary

MeasureTime frame
The location of Aneurysm/DissectionThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Age for each participantThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Gender for each participantThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Height for each participantThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Weight for each participantThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Contact information for each participantThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Past Medical History including disease history, surgical history, and family medical historyThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Lifestyle including smoking history and drinking, specify how many years smoking or drinking lasted and detail quantity per dayThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Exon sequencing data of each participantSequencing will be carried out in an average of 3 months after sample recruiting
Serum biomarker screening data of each participantScreening will be carried out in an average of 3 months after sample recruiting
The size of Aneurysm/DissectionThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:blood lipidThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:blood glucoseThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:uric acidThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:ureaThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:creatinineThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:C reactive proteinThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:d dimeThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Drug treatmentThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Surgery typeThese data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Prognosis information: all-cause deathThese data is collected during follow-up visit at 3/6/12 months after discharge
Prognosis information: whether recidivation happenedThese data is collected during follow-up visit at 3/6/12 months after discharge
Prognosis information including: whether other related disease happenedThese data is collected during follow-up visit at 3/6/12 months after discharge

Countries

China

Contacts

Primary ContactYulin Li, PHD
lyllyl_1111@163.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026